Clarkson welcomes Ichor Therapeutics, Inc. with open house

POTSDAM — Clarkson University officially welcomed Ichor Therapeutics, Inc. to its campus Tuesday with a lavish open house in Peyton Hall, complete with an open bar, charcuterie and a tour of the science facilities.
Ichor, pronounced “eye-core,” is a vertically integrated research organization that broadly focuses on the study of aging and aging pathways. Chief Executive Officer Kelsey Moody said in a speech at the open house that Ichor develops new drugs, supporting a wide range of pharmaceutical clients in addition to internal programs.
For instance, Ichor is currently developing an enzyme therapy called Lysoclear which seeks to treat macular degeneration, the leading cause of impaired eyesight in the aging.

Related Keywords

Peyton Hall , Anthonyg Collins , Kelsey Moody , Clarkson University , Ichor Therapeutics Inc , Syracuse University , Moody , Ichor Therapeutics , Executive Officer Kelsey Moody , President Anthony , Silicon Valley , பெய்டன் மண்டபம் , கெல்ஸீ மனநிலை , கிளார்க்சன் பல்கலைக்கழகம் , சிராகஸ் பல்கலைக்கழகம் , மனநிலை , ப்ரெஸிடெஂட் அந்தோணி , சிலிக்கான் பள்ளத்தாக்கு ,